Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 1
1987 1
1988 2
1989 3
1990 3
1991 12
1992 6
1993 3
1994 16
1995 6
1996 11
1997 22
1998 13
1999 24
2000 13
2001 14
2002 20
2003 16
2004 19
2005 15
2006 14
2007 21
2008 11
2009 15
2010 20
2011 15
2012 19
2013 22
2014 31
2015 63
2016 77
2017 58
2018 70
2019 90
2020 92
2021 96
Text availability
Article attribute
Article type
Publication date

Search Results

852 results
Results by year
Filters applied: . Clear all
Page 1
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, Wai-Sun Wong V, Yilmaz Y, George J, Fan J, Vos MB. Younossi Z, et al. Hepatology. 2019 Jun;69(6):2672-2682. doi: 10.1002/hep.30251. Hepatology. 2019. PMID: 30179269 Free article. Review.
Because of the close association of NAFLD with type 2 diabetes (T2DM) and obesity, the latest models predict that the prevalence of NAFLD and NASH will increase, causing a tremendous clinical and economic burden and poor patient-reported outcomes. Nonetheless, there is no …
Because of the close association of NAFLD with type 2 diabetes (T2DM) and obesity, the latest models predict that the prevalence of NAFLD an …
The Use of Rifaximin in Patients With Cirrhosis.
Caraceni P, Vargas V, Solà E, Alessandria C, de Wit K, Trebicka J, Angeli P, Mookerjee RP, Durand F, Pose E, Krag A, Bajaj JS, Beuers U, Ginès P; Liverhope Consortium. Caraceni P, et al. Hepatology. 2021 Sep;74(3):1660-1673. doi: 10.1002/hep.31708. Epub 2021 Jun 7. Hepatology. 2021. PMID: 33421158 Review.
However, the use of rifaximin for prevention or treatment of other complications, including spontaneous bacterial peritonitis or other bacterial infections, is not accepted because evidence by clinical trials is still very weak. The present review deals in the first part w …
However, the use of rifaximin for prevention or treatment of other complications, including spontaneous bacterial peritonitis or other bacte …
Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.
Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Bertolini A, et al. Hepatology. 2020 Nov;72(5):1864-1872. doi: 10.1002/hep.31480. Epub 2020 Oct 20. Hepatology. 2020. PMID: 32702162 Free PMC article. Review.
In conclusion, these initial observations suggest that the prevalence of abnormal LFTs is high in COVID-19 patients, but that the clinical relevance is limited and that treatment is not required. The mechanisms underlying abnormal LFTs in COVID-19 are likely multifactorial …
In conclusion, these initial observations suggest that the prevalence of abnormal LFTs is high in COVID-19 patients, but that the clinica
The Prevalence of Wilson's Disease: An Update.
Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. Sandahl TD, et al. Hepatology. 2020 Feb;71(2):722-732. doi: 10.1002/hep.30911. Epub 2020 Jan 31. Hepatology. 2020. PMID: 31449670 Review.
The "Scheinberg-Sternlieb Estimate" is still widely used, although more recent clinical and genetic studies of higher quality are now available. In the present study, we included these data to update the prevalence estimate. ...We identified 4 recent clinical studie …
The "Scheinberg-Sternlieb Estimate" is still widely used, although more recent clinical and genetic studies of higher quality are now …
Liver Injury and Failure in Critical Illness.
Horvatits T, Drolz A, Trauner M, Fuhrmann V. Horvatits T, et al. Hepatology. 2019 Dec;70(6):2204-2215. doi: 10.1002/hep.30824. Hepatology. 2019. PMID: 31215660 Review.
., hemodynamic, inflammatory, or drug induced) is key to a better understanding of clinical manifestations, prognostic implications, as well as diagnostic and therapeutic options of acquired liver injury and failure. ...
., hemodynamic, inflammatory, or drug induced) is key to a better understanding of clinical manifestations, prognostic implications, …
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.
Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, Zhu AX. Sirica AE, et al. Hepatology. 2019 Apr;69(4):1803-1815. doi: 10.1002/hep.30289. Epub 2019 Mar 25. Hepatology. 2019. PMID: 30251463 Free PMC article. Review.
An integrated systems approach to classifying heterogeneous iCCA subtypes will be further highlighted, and recent clinical trials and emerging targeted therapies will be reviewed, along with recommendations for future translational research opportunities. Established inter …
An integrated systems approach to classifying heterogeneous iCCA subtypes will be further highlighted, and recent clinical trials and …
A practical approach to nutritional screening and assessment in cirrhosis.
Tandon P, Raman M, Mourtzakis M, Merli M. Tandon P, et al. Hepatology. 2017 Mar;65(3):1044-1057. doi: 10.1002/hep.29003. Epub 2017 Feb 6. Hepatology. 2017. PMID: 28027577 Review.
This article summarizes the clinically relevant evidence and presents key issues, tools, and clinical options that are applicable to patients with cirrhosis. The definition, etiology, and clinically relevant outcomes associated with malnutrition are reviewed. ...Multicente …
This article summarizes the clinically relevant evidence and presents key issues, tools, and clinical options that are applicable to …
Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.
Lonardo A, Nascimbeni F, Ballestri S, Fairweather D, Win S, Than TA, Abdelmalek MF, Suzuki A. Lonardo A, et al. Hepatology. 2019 Oct;70(4):1457-1469. doi: 10.1002/hep.30626. Epub 2019 Sep 23. Hepatology. 2019. PMID: 30924946 Free PMC article. Review.
Based on computer modeling, female and male livers are metabolically distinct with unique regulators modulating sex-specific metabolic outcomes. Analysis of the literature reveals that most published clinical and epidemiological studies fail to examine sex differences appr …
Based on computer modeling, female and male livers are metabolically distinct with unique regulators modulating sex-specific metabolic outco …
Hepatitis B cure: From discovery to regulatory approval.
Lok AS, Zoulim F, Dusheiko G, Ghany MG. Lok AS, et al. Hepatology. 2017 Oct;66(4):1296-1313. doi: 10.1002/hep.29323. Epub 2017 Aug 1. Hepatology. 2017. PMID: 28762522 Free PMC article.
The introduction of these novel compounds for chronic hepatitis B necessitates a standardized appraisal of the efficacy and safety of these treatments and definitions of new or additional endpoints to inform clinical trials. To move the field forward and to expedite the pa …
The introduction of these novel compounds for chronic hepatitis B necessitates a standardized appraisal of the efficacy and safety of these …
852 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page